IN THE RECENT YEARS, THE PHARMACEUTICAL TECHNOLOGY FIELD HAS EXPERIENCED A REMARKABLE TRANSFORMATION THANKS TO THE DEVELOPMENT OF NOVEL DRUG DELIVERY SYSTEMS. THE DESIGN OF INNOVATIVE FORMULATIONS, SUCH AS HYDROGEL AND NANOPARTICLES (NPS) SYSTEMS, AIMS TO CONTROL DRUG AVAILABILITY, TARGET SPECIFIC CELLS OR TISSUES AND PROLONG THE THERAPEUTIC EFFECT OVER TIME. MUSCULOSKELETAL DISEASES ARE CONSIDERED AN INCREASING GLOBAL HEALTHCARE PROBLEM, WITH MORE THAN 150 DISTINCT PATHOLOGIES AND AN ESTIMATED INCIDENCE OF 1.71 BILLION PEOPLE WORLDWIDE. SPECIFICALLY, TENDINOPATHIES ARE AMONG THE MOST COMMON MUSCULOSKELETAL DISORDERS AND INCLUDE A WIDE AND DIVERSE RANGE OF DISORDERS THAT COMPROMISE THE INTRINSIC REGENERATIVE CAPABILITIES OF TENDON TISSUE FOLLOWING CHRONIC ALTERATION OF THE TISSUE HOMEOSTASIS. THE TREATMENT OF TENDON-RELATED DISORDERS MAINLY DEPENDS ON THE SPECIFICALLY AFFECTED TENDON AND THE TYPE OF INJURY, WITH SURGICAL INTERVENTIONS AND PHYSIOTHERAPY-BASED ACTIVITIES CONSIDERED AS COMMON THERAPEUTICAL APPROACHES IN COMBINATION WITH ADMINISTRATION OF THERAPEUTICS USED FOR THE SYMPTOMATIC RELIEF OF PAIN AND INFLAMMATORY SYMPTOMATOLOGY. THEREFORE, THERE IS AN INCREASING NEED FOR THE DEVELOPMENT OF NOVEL THERAPEUTICAL TOOLS CAPABLE OF MEDIATING THE INFLAMMATORY STATE, SUPPORT THE REGENERATION PROCESS AND IMPROVE THE RESTITUTION OF THE ORIGINAL TISSUE MATRIX AND MECHANICAL PROPERTIES. IN THIS THESIS, DIFFERENT HYDROGEL AND NPS-BASED FORMULATIONS WERE DEVELOPED AS DRUG DELIVERY SYSTEMS FOR THE DELIVERY OF BIOLOGICALLY COMPLEX CARGOS AND THE TREATMENT OF TENDINOPATHY-DERIVED CONDITIONS. FIRST, IN-SITU GELLABLE INVERSE ELECTRON DEMAND DIELS-ALDER (IEDDA)-CROSSLINKED POLY(ETHYLENE GLYCOL) (PEG) HYDROGEL MICROSPHERES (MPS) WERE DEVELOPED VIA WATER-IN-OIL EMULSIFICATION AS A POTENTIAL PROTEIN DELIVERY SYSTEM. THE DEVELOPED HYDROGEL MPS PRODUCTION WAS OPTIMIZED, AND THE PRODUCED MPS WERE CHARACTERIZED IN TERMS OF PHYSICOCHEMICAL AND MORPHOLOGICAL PROPERTIES, RHEOLOGICAL AND SWELLING BEHAVIOR. THE SYSTEM SHOWED A HIGH PROTEIN ENCAPSULATION EFFICIENCY AND CELL BIOCOMPATIBILITY, DEMONSTRATING ITS POTENTIAL USE AS DRUG VEHICLE. SECOND, A HYALURONIC ACID (HA) AND PEG IN-SITU GELLABLE IEDDA-CROSSLINKED AND HEPARIN-FUNCTIONALIZED HYDROGEL FORMULATION WAS PRODUCED FOR THE ENCAPSULATION OF AMNIOTIC EPITHELIAL STEM CELLS (AEC)-DERIVED CONDITIONED MEDIA (CM). THE SYSTEM WAS ALSO STUDIED IN TERMS OF PHYSICOCHEMICAL, MORPHOLOGICAL, AND RHEOLOGICAL CHARACTERISTICS, DISPLAYING FAST CROSSLINKING KINETICS. HEPARIN-FUNCTIONALIZED HYDROGELS ALLOWED THE SUSTAINED RELEASE OF PREDOMINANT GROWTH FACTORS FROM AEC-CM OVER 14 DAYS. IN VITRO STUDIES IN PERIPHERAL BLOOD MONONUCLEAR CELLS (PBMCS) SHOWED AN ENHANCED SUPPRESSION EFFICACY AND A SIGNIFICANT SHIFT TOWARDS M2 MACROPHAGE PHENOTYPE IN COMPARISON WITH NON-ENCAPSULATED AEC-CM, PROVING ITS POTENTIAL AS AN ALTERNATIVE IMMUNOMODULATORY THERAPEUTIC TOOL. THIRD, MESENCHYMAL STEM CELLS (MSC)-DERIVED EXTRACELLULAR VESICLES (EVS) WERE USED TO PRODUCE LIPIDIC HYBRID NPS BY MICROFLUIDIC-SONICATION FOR COLLAGEN TYPE I (COL1A1) MRNA ENCAPSULATION AND DELIVERY IN TENDON PROGENITOR STEM CELLS (TSPCS). THE FORMULATION WAS OPTIMIZED AND CHARACTERIZED IN TERMS OF PHYSICOCHEMICAL PROPERTIES, PROVING THAT MSC-HYB NPS ENCAPSULATED MRNA AND INCLUDED EVS-DERIVED SURFACE PROTEINS. MOREOVER, MSC-HYB NPS REMAINED HIGHLY BIOCOMPATIBLE WITH TSPCS AND PROVED TO BE FUNCTIONAL MRNA DELIVERY AGENTS WITH CERTAIN LIMITATIONS IN COMPARISON WITH LIPID NANOPARTICLES (LNPS). OVERALL, THIS DISSERTATION PRESENTED DIVERSE INNOVATIVE ALTERNATIVES FOR THE DESIGN OF HYDROGEL AND NPS-BASED DRUG DELIVERY SYSTEMS FOR THE TREATMENT OF TENDINOPATHIC-DERIVED CONDITIONS, DEMONSTRATING THE SIGNIFICANT ROLE AND POTENTIAL OF DRUG DELIVERY FOR ADVANCED REGENERATIVE MEDICINE APPLICATIONS.
HYDROGELS AND LIPID-BASED DRUG DELIVERY SYSTEMS FOR TENDON THERAPY WITH IMMUNOMODULATORY AND PRO-REGENERATIVE APPLICATIONS
PAREJA TELLO, Ruben
2025
Abstract
IN THE RECENT YEARS, THE PHARMACEUTICAL TECHNOLOGY FIELD HAS EXPERIENCED A REMARKABLE TRANSFORMATION THANKS TO THE DEVELOPMENT OF NOVEL DRUG DELIVERY SYSTEMS. THE DESIGN OF INNOVATIVE FORMULATIONS, SUCH AS HYDROGEL AND NANOPARTICLES (NPS) SYSTEMS, AIMS TO CONTROL DRUG AVAILABILITY, TARGET SPECIFIC CELLS OR TISSUES AND PROLONG THE THERAPEUTIC EFFECT OVER TIME. MUSCULOSKELETAL DISEASES ARE CONSIDERED AN INCREASING GLOBAL HEALTHCARE PROBLEM, WITH MORE THAN 150 DISTINCT PATHOLOGIES AND AN ESTIMATED INCIDENCE OF 1.71 BILLION PEOPLE WORLDWIDE. SPECIFICALLY, TENDINOPATHIES ARE AMONG THE MOST COMMON MUSCULOSKELETAL DISORDERS AND INCLUDE A WIDE AND DIVERSE RANGE OF DISORDERS THAT COMPROMISE THE INTRINSIC REGENERATIVE CAPABILITIES OF TENDON TISSUE FOLLOWING CHRONIC ALTERATION OF THE TISSUE HOMEOSTASIS. THE TREATMENT OF TENDON-RELATED DISORDERS MAINLY DEPENDS ON THE SPECIFICALLY AFFECTED TENDON AND THE TYPE OF INJURY, WITH SURGICAL INTERVENTIONS AND PHYSIOTHERAPY-BASED ACTIVITIES CONSIDERED AS COMMON THERAPEUTICAL APPROACHES IN COMBINATION WITH ADMINISTRATION OF THERAPEUTICS USED FOR THE SYMPTOMATIC RELIEF OF PAIN AND INFLAMMATORY SYMPTOMATOLOGY. THEREFORE, THERE IS AN INCREASING NEED FOR THE DEVELOPMENT OF NOVEL THERAPEUTICAL TOOLS CAPABLE OF MEDIATING THE INFLAMMATORY STATE, SUPPORT THE REGENERATION PROCESS AND IMPROVE THE RESTITUTION OF THE ORIGINAL TISSUE MATRIX AND MECHANICAL PROPERTIES. IN THIS THESIS, DIFFERENT HYDROGEL AND NPS-BASED FORMULATIONS WERE DEVELOPED AS DRUG DELIVERY SYSTEMS FOR THE DELIVERY OF BIOLOGICALLY COMPLEX CARGOS AND THE TREATMENT OF TENDINOPATHY-DERIVED CONDITIONS. FIRST, IN-SITU GELLABLE INVERSE ELECTRON DEMAND DIELS-ALDER (IEDDA)-CROSSLINKED POLY(ETHYLENE GLYCOL) (PEG) HYDROGEL MICROSPHERES (MPS) WERE DEVELOPED VIA WATER-IN-OIL EMULSIFICATION AS A POTENTIAL PROTEIN DELIVERY SYSTEM. THE DEVELOPED HYDROGEL MPS PRODUCTION WAS OPTIMIZED, AND THE PRODUCED MPS WERE CHARACTERIZED IN TERMS OF PHYSICOCHEMICAL AND MORPHOLOGICAL PROPERTIES, RHEOLOGICAL AND SWELLING BEHAVIOR. THE SYSTEM SHOWED A HIGH PROTEIN ENCAPSULATION EFFICIENCY AND CELL BIOCOMPATIBILITY, DEMONSTRATING ITS POTENTIAL USE AS DRUG VEHICLE. SECOND, A HYALURONIC ACID (HA) AND PEG IN-SITU GELLABLE IEDDA-CROSSLINKED AND HEPARIN-FUNCTIONALIZED HYDROGEL FORMULATION WAS PRODUCED FOR THE ENCAPSULATION OF AMNIOTIC EPITHELIAL STEM CELLS (AEC)-DERIVED CONDITIONED MEDIA (CM). THE SYSTEM WAS ALSO STUDIED IN TERMS OF PHYSICOCHEMICAL, MORPHOLOGICAL, AND RHEOLOGICAL CHARACTERISTICS, DISPLAYING FAST CROSSLINKING KINETICS. HEPARIN-FUNCTIONALIZED HYDROGELS ALLOWED THE SUSTAINED RELEASE OF PREDOMINANT GROWTH FACTORS FROM AEC-CM OVER 14 DAYS. IN VITRO STUDIES IN PERIPHERAL BLOOD MONONUCLEAR CELLS (PBMCS) SHOWED AN ENHANCED SUPPRESSION EFFICACY AND A SIGNIFICANT SHIFT TOWARDS M2 MACROPHAGE PHENOTYPE IN COMPARISON WITH NON-ENCAPSULATED AEC-CM, PROVING ITS POTENTIAL AS AN ALTERNATIVE IMMUNOMODULATORY THERAPEUTIC TOOL. THIRD, MESENCHYMAL STEM CELLS (MSC)-DERIVED EXTRACELLULAR VESICLES (EVS) WERE USED TO PRODUCE LIPIDIC HYBRID NPS BY MICROFLUIDIC-SONICATION FOR COLLAGEN TYPE I (COL1A1) MRNA ENCAPSULATION AND DELIVERY IN TENDON PROGENITOR STEM CELLS (TSPCS). THE FORMULATION WAS OPTIMIZED AND CHARACTERIZED IN TERMS OF PHYSICOCHEMICAL PROPERTIES, PROVING THAT MSC-HYB NPS ENCAPSULATED MRNA AND INCLUDED EVS-DERIVED SURFACE PROTEINS. MOREOVER, MSC-HYB NPS REMAINED HIGHLY BIOCOMPATIBLE WITH TSPCS AND PROVED TO BE FUNCTIONAL MRNA DELIVERY AGENTS WITH CERTAIN LIMITATIONS IN COMPARISON WITH LIPID NANOPARTICLES (LNPS). OVERALL, THIS DISSERTATION PRESENTED DIVERSE INNOVATIVE ALTERNATIVES FOR THE DESIGN OF HYDROGEL AND NPS-BASED DRUG DELIVERY SYSTEMS FOR THE TREATMENT OF TENDINOPATHIC-DERIVED CONDITIONS, DEMONSTRATING THE SIGNIFICANT ROLE AND POTENTIAL OF DRUG DELIVERY FOR ADVANCED REGENERATIVE MEDICINE APPLICATIONS.| File | Dimensione | Formato | |
|---|---|---|---|
|
1_Ruben_ParejaTello_Thesis.pdf
accesso aperto
Licenza:
Tutti i diritti riservati
Dimensione
7.48 MB
Formato
Adobe PDF
|
7.48 MB | Adobe PDF | Visualizza/Apri |
|
1_Ruben_ParejaTello_Thesis_1.pdf
accesso aperto
Licenza:
Tutti i diritti riservati
Dimensione
7.48 MB
Formato
Adobe PDF
|
7.48 MB | Adobe PDF | Visualizza/Apri |
I documenti in UNITESI sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
https://hdl.handle.net/20.500.14242/385484
URN:NBN:IT:UNISA-385484